The At5g05820 Antibody (Product Code: CSB-PA724888XA01DOA) is a polyclonal rabbit-derived antibody specifically designed to target the protein encoded by the At5g05820 gene in Arabidopsis thaliana. This antibody is primarily used for detecting and analyzing the corresponding protein in experimental settings, such as Western Blot (WB) and Enzyme-Linked Immunosorbent Assay (ELISA). Its development aligns with broader efforts to study gene expression, protein localization, and functional roles in plant biology, particularly in the model organism Arabidopsis .
The At5g05820 Antibody is optimized for detecting the At5g05820 protein in Arabidopsis lysates. Its polyclonal nature ensures broad epitope recognition, enhancing sensitivity for protein identification .
This antibody can be used in ELISA assays to quantify At5g05820 protein levels in Arabidopsis extracts. Its compatibility with enzymatic tags (e.g., horseradish peroxidase) enables high-throughput screening .
The antibody was raised against a recombinant At5g05820 protein, ensuring specificity for the target. This approach minimizes cross-reactivity with non-target proteins in Arabidopsis .
Purification: Antigen affinity chromatography ensures high purity and binding specificity.
Clonality: Polyclonal antibodies recognize multiple epitopes, improving detection robustness compared to monoclonal alternatives .
While specific studies using the At5g05820 Antibody are not detailed in publicly available literature, its design aligns with established methods for studying gene function in Arabidopsis. For example:
Gene Expression Analysis
Quantifying At5g05820 protein levels in developmental or stress-response studies.
Comparing expression across Arabidopsis tissues (e.g., leaves, roots).
Protein Localization
Identifying subcellular localization patterns using immunofluorescence (if conjugated to fluorescent tags).
Functional Studies
Investigating interactions with other proteins via co-immunoprecipitation (IP).
At5g05820 is a gene locus in Arabidopsis thaliana that encodes a protein involved in plant developmental processes and stress responses. Developing antibodies against this protein is critical for studying its expression patterns, subcellular localization, and functional interactions in plant tissues. The protein's involvement in fundamental plant processes makes it a valuable target for immunological detection methods aimed at understanding plant cellular mechanisms.
Researchers typically develop both polyclonal and monoclonal antibodies against specific epitopes of the At5g05820 protein product. These antibodies enable visualization of expression patterns across different tissues, developmental stages, and in response to various environmental stimuli. The development process involves careful epitope selection to ensure specificity while maintaining functional detection capacity across experimental conditions .
Validating antibody specificity is essential for ensuring experimental reliability. For At5g05820 antibodies, validation should include multiple complementary approaches:
Genetic validation: Testing antibody reactivity in At5g05820 knockout or knockdown lines, which should show absent or significantly reduced signal compared to wild-type plants.
Western blot analysis: Confirming detection of a single band at the expected molecular weight, with additional validation using recombinant protein standards.
Peptide competition assays: Pre-incubating the antibody with immunizing peptide should abolish signal in subsequent applications.
Cross-reactivity testing: Evaluating potential cross-reactivity with closely related proteins to ensure signal specificity.
Mass spectrometry validation: Confirming that immunoprecipitated proteins correspond to At5g05820 through LC-MS/MS analysis .
| Characteristic | Polyclonal Antibodies | Monoclonal Antibodies | Research Implications |
|---|---|---|---|
| Epitope recognition | Multiple epitopes | Single epitope | Monoclonals provide consistent epitope targeting |
| Production method | Immunized animals (typically rabbits) | Hybridoma technology (typically rats or mice) | Monoclonals offer unlimited supply of identical antibodies |
| Batch consistency | Significant batch-to-batch variation | High consistency between batches | Monoclonals provide better experimental reproducibility |
| Sensitivity | Generally higher sensitivity | May have lower sensitivity | Polyclonals may detect lower abundance targets |
| Applications | Excellent for initial detection | Preferred for specific epitope targeting | Application-dependent selection required |
| Cross-reactivity | Higher potential for cross-reactivity | More specific binding | Monoclonals reduce false positives in complex samples |
The choice between polyclonal and monoclonal antibodies should be guided by experimental requirements. Novel monoclonal antibody development techniques, such as those used for plant epitopes, can provide highly specific reagents for At5g05820 detection . Monoclonal antibodies often require extensive screening processes to identify clones with optimal specificity and sensitivity characteristics .
Successful immunohistochemistry with At5g05820 antibodies requires careful optimization of multiple parameters:
Sample preparation protocol:
Fix plant tissues in 4% paraformaldehyde in PBS for 2-4 hours
Dehydrate through an ethanol series (30%, 50%, 70%, 85%, 95%, 100%)
Clear with xylene or alternative clearing agents
Embed in paraffin and section at 8-10 μm thickness
Mount on positively-charged slides
Antigen retrieval methods:
Heat-induced epitope retrieval using citrate buffer (pH 6.0) at 95°C for 20 minutes
Enzymatic retrieval using proteinase K (1-5 μg/ml for 5-15 minutes)
Optimization is critical as over-retrieval can damage tissue morphology
Blocking and antibody incubation:
Block with 5% normal serum and 0.3% Triton X-100 in PBS for 1 hour
Incubate with primary At5g05820 antibody (typically 1:100-1:500 dilution) overnight at 4°C
Wash 3× with PBS containing 0.1% Tween-20
Incubate with appropriate secondary antibody for 1-2 hours at room temperature
Wash 3× with PBS containing 0.1% Tween-20
Counterstain and mount appropriately
Each step requires careful optimization for the specific tissue type and fixation method used. The dilution and incubation conditions may need adjustment based on antibody affinity and target abundance .
Proper storage is critical for maintaining antibody functionality over time:
Storage recommendations:
Store unconjugated antibodies at -20°C in small aliquots to minimize freeze-thaw cycles
For conjugated antibodies, follow manufacturer recommendations (typically 2-8°C protected from light)
Avoid repeated freeze-thaw cycles by preparing appropriately sized single-use aliquots
Include a protein carrier (0.1-0.5% BSA) and preservative (0.02-0.05% sodium azide) in storage buffer
Stability monitoring:
Test antibody performance periodically against a reference sample
Document lot numbers and performance characteristics
Consider implementing a quality control program for critical antibodies
Reconstitution guidelines:
Centrifuge vials briefly before opening
Allow to equilibrate to room temperature before opening to prevent condensation
Reconstitute lyophilized antibodies precisely according to manufacturer instructions
Following storage recommendations similar to those for other research antibodies, such as storing working solutions at 4°C protected from light and avoiding freezing of conjugated antibodies, will help maintain efficacy .
When studying low-abundance At5g05820 protein, several signal amplification techniques can significantly improve detection:
Signal amplification methods:
Tyramide Signal Amplification (TSA): Provides 10-100× signal enhancement through catalyzed reporter deposition
DELFIA (Dissociation-Enhanced Lanthanide Fluorescence Immunoassay): Utilizes time-resolved fluorescence to reduce background and increase sensitivity
Proximity Ligation Assay (PLA): Enables detection of protein interactions with single-molecule sensitivity
Polymer-based detection systems: Multiple secondary antibodies on a polymer backbone enhance signal without increasing background
Sample enrichment strategies:
Subcellular fractionation to concentrate target compartments
Immunoprecipitation followed by Western blotting
Protein concentration techniques prior to analysis
Assay optimization for low abundance targets:
Extended primary antibody incubation (overnight at 4°C)
Increased antibody concentration (empirically determined)
Reduction of detergent concentration in washing buffers
Use of high-sensitivity substrates for enzymatic detection
DELFIA assays offer particular advantages for low-abundance targets due to their wide dynamic range and low background, making them suitable for detecting even small amounts of At5g05820 protein in complex plant tissue samples .
Non-specific binding is a common challenge in plant tissue immunoassays that can be addressed through several strategies:
Blocking optimization:
Test different blocking agents (BSA, casein, normal serum from secondary antibody host species)
Extend blocking time (2 hours at room temperature or overnight at 4°C)
Consider dual blocking strategies (protein blocker followed by irrelevant IgG)
Buffer modifications:
Increase salt concentration (150-500 mM NaCl) to reduce ionic interactions
Optimize detergent type and concentration (0.1-0.3% Triton X-100 or Tween-20)
Add 1-5% polyethylene glycol to reduce hydrophobic interactions
Antibody preparation:
Pre-adsorb antibody against plant tissue from knockout lines
Use affinity-purified antibody preparations
Perform cross-adsorption against related plant proteins
Protocol refinements:
Increase washing stringency (duration, detergent concentration)
Optimize antibody dilution to minimize background while maintaining specific signal
Consider alternative fixation methods that better preserve epitope while reducing background
Implementing these strategies systematically, similar to approaches used in monoclonal antibody development for plant antigens, can significantly improve signal-to-noise ratio in At5g05820 detection assays .
When faced with contradictory results from At5g05820 antibody experiments, a systematic investigation approach is essential:
Methodological considerations:
Epitope differences: Different antibodies may recognize different epitopes that could be differentially accessible depending on protein conformation or interactions
Assay-specific limitations: Results from different methods (e.g., Western blot vs. immunohistochemistry) may reflect methodological differences rather than biological contradictions
Sample preparation effects: Different fixation or extraction protocols may affect epitope accessibility
Experimental design evaluation:
Assess control adequacy (positive, negative, and isotype controls)
Compare normalization methods and quantification approaches
Evaluate statistical power and sample sizes
Reconciliation strategies:
| Contradiction Type | Investigation Approach | Resolution Strategy |
|---|---|---|
| Presence/Absence | Test with multiple antibodies recognizing different epitopes | Confirm with genetic approaches (knockout/knockdown) |
| Localization differences | Compare fixation and permeabilization methods | Use epitope-tagged versions for validation |
| Quantitative differences | Analyze dynamic range of different assay methods | Apply absolute quantification using standard curves |
| Temporal/spatial discrepancies | Examine developmental timing and tissue specificity | Design time-course and tissue-specific experiments |
Systematic comparison of results obtained with different antibodies, similar to approaches used for pectic homogalacturonan epitope characterization, can help identify the source of contradictions and resolve apparent discrepancies .
Multiplex detection allows simultaneous analysis of At5g05820 along with other proteins of interest, providing valuable contextual information:
Immunofluorescence multiplexing strategies:
Primary antibodies from different host species: Use species-specific secondary antibodies with distinct fluorophores
Directly conjugated primary antibodies: Eliminate secondary antibody cross-reactivity concerns
Sequential staining protocols: Complete labeling with one antibody before blocking and applying the next
Spectral unmixing techniques: Computational separation of overlapping fluorescent signals
Flow cytometry applications:
Combine At5g05820 antibody with markers for different cell types or cellular states
Use fluorophores with minimal spectral overlap
Include proper compensation controls
Experimental considerations for successful multiplexing:
| Multiplexing Challenge | Solution | Implementation Note |
|---|---|---|
| Cross-reactivity | Test each antibody individually first | Establish single-plex protocols before combining |
| Signal interference | Choose compatible fluorophores or enzyme systems | Consider brightness, spectral separation, and potential energy transfer |
| Epitope accessibility | Optimize antigen retrieval for multiple targets | May require compromise conditions suitable for all targets |
| Analysis complexity | Use appropriate controls for each target | Include single-stained samples for compensation |
Flow cytometry applications with antibodies like the PerCP-Cy5.5 conjugated antibody described in the search results demonstrate how proper fluorophore selection and protocol optimization can enable successful multiplex detection .
Proper normalization is essential for meaningful comparisons of At5g05820 expression across different samples:
Western blot normalization approaches:
Housekeeping protein normalization: Normalize to stable reference proteins (e.g., actin, tubulin)
Total protein normalization: Use stain-free gels or total protein stains (Ponceau S, SYPRO Ruby)
Loading control peptides: Spike-in synthetic peptides for absolute quantification
Immunohistochemistry quantification:
Relative measurement: Compare signal intensity to internal control regions
Cell-type specific normalization: Normalize to cell-type specific markers
Standardized acquisition: Use identical imaging parameters across all samples
ELISA and immunoassay normalization:
Standard curve calibration: Generate standard curves with purified At5g05820 protein
Parallel line analysis: Compare dose-response curves between samples and standards
Internal controls: Include reference samples in each assay plate
The wide dynamic range of DELFIA immunoassays makes them particularly suitable for quantitative analysis of At5g05820 across samples with varying expression levels .
Post-translational modifications (PTMs) can significantly affect antibody binding and must be considered when interpreting results:
Common PTMs affecting antibody recognition:
Phosphorylation
Glycosylation
Ubiquitination
Proteolytic processing
Conformational changes
Experimental approaches to address PTM concerns:
Epitope-specific antibodies: Use antibodies that specifically recognize modified or unmodified forms
Enzymatic treatments: Treat samples with phosphatases, glycosidases, or other enzymes to remove specific modifications
Mobility shift analysis: Compare migration patterns before and after enzymatic treatment
Modification-specific detection methods: Use PTM-specific stains or antibodies in parallel
Interpretation strategies:
| Observation | Possible PTM Explanation | Verification Approach |
|---|---|---|
| Multiple bands in Western blot | Different modification states or proteolytic processing | Enzymatic treatment to remove modifications |
| Differential detection across tissues | Tissue-specific modification patterns | Compare with modification-specific antibodies |
| Altered signal after treatments | Induced modifications affecting epitope accessibility | Pre-treat samples to remove modifications |
| Subcellular localization differences | Compartment-specific modifications | Co-localization with modification-specific markers |
Understanding the potential impact of PTMs on antibody binding is crucial for accurate interpretation of At5g05820 detection results, particularly when comparing results across different experimental conditions or tissue types .
Sources of variability in At5g05820 antibody experiments:
Technical variation (antibody performance, protocol execution)
Biological variation (sample heterogeneity, developmental factors)
Instrument variation (detection sensitivity, calibration differences)
Statistical approaches for robust analysis:
Power analysis: Determine appropriate sample size before experiments
Nested design analysis: Account for technical replicates within biological replicates
Mixed-effects models: Separate fixed effects (experimental treatments) from random effects (batch variation)
Non-parametric methods: For data that does not meet normality assumptions
Multiple comparison corrections: Control family-wise error rate or false discovery rate
Experimental design recommendations:
| Research Question | Design Recommendation | Statistical Approach |
|---|---|---|
| Expression comparison across genotypes | Balanced design with matched controls | ANOVA with post-hoc tests |
| Developmental time course | Longitudinal sampling with internal controls | Repeated measures analysis |
| Treatment response | Include dose-response relationships | Regression analysis |
| Localization patterns | Quantitative image analysis with multiple fields | Mixed models with spatial components |
Reporting standards:
Clearly describe normalization methods
Report both technical and biological replication
Include measures of variability (standard deviation, confidence intervals)
Provide raw data when possible
CRISPR technology offers powerful complementary approaches to traditional antibody-based detection of At5g05820:
Genome editing applications:
Knockout validation: Generate complete At5g05820 knockout lines for definitive antibody validation
Epitope tagging: Add endogenous tags (FLAG, HA, GFP) to enable detection with validated tag antibodies
Reporter knock-ins: Insert fluorescent protein coding sequences for direct visualization
Allelic series: Create mutations affecting specific protein domains to correlate with antibody binding
Advantages over traditional antibody approaches:
Endogenous expression levels maintain physiological relevance
Tag-based detection eliminates concerns about antibody specificity
Visualization possible in live tissues without fixation artifacts
Enables temporal and spatial expression studies with minimal perturbation
Experimental considerations:
| Application | Advantages | Limitations | Implementation Notes |
|---|---|---|---|
| C-terminal tagging | Maintains endogenous regulation | May disrupt C-terminal functions | Test multiple tag positions |
| N-terminal tagging | Avoids disrupting C-terminal motifs | May affect signal peptide function | Consider internal tagging if termini are functional |
| Knock-in reporters | Direct visualization without antibodies | May alter protein function | Use self-cleaving peptides to separate tag from protein |
| Conditional alleles | Temporal and spatial control | More complex design | Combine with tissue-specific Cre/lox systems |
These approaches can provide valuable complementary data to traditional antibody-based studies, particularly when antibody specificity is challenging to validate or when dynamic processes need to be studied in living tissues.
Advanced mass spectrometry techniques provide powerful tools for antibody validation:
Mass spectrometry validation approaches:
Immunoprecipitation-mass spectrometry (IP-MS): Verify that antibodies capture the intended target protein
Parallel reaction monitoring (PRM): Targeted analysis of specific At5g05820 peptides
Data-independent acquisition (DIA): Comprehensive analysis of all detectable peptides
Cross-linking mass spectrometry (XL-MS): Map epitope-paratope interactions
Workflow for antibody validation by mass spectrometry:
Immunoprecipitate target protein using the antibody
Process samples for proteomic analysis (reduction, alkylation, digestion)
Analyze by LC-MS/MS to identify captured proteins
Compare identified proteins with expected target sequence
Quantify relative abundance of target vs. non-target proteins
Advanced applications:
Epitope mapping: Identify the specific peptide sequences recognized by the antibody
Cross-reactivity profiling: Identify off-target proteins that share epitope sequences
PTM analysis: Determine if modifications affect antibody recognition
Absolute quantification: Use isotope-labeled peptide standards for absolute quantification
These mass spectrometry approaches provide objective, sequence-level validation of antibody specificity that complements traditional validation methods and can help resolve contradictory results from different antibodies targeting the same protein.
Emerging computational approaches are transforming antibody research and will significantly impact At5g05820 studies:
Machine learning applications in antibody research:
Epitope prediction: Computational identification of optimal antigenic regions of At5g05820
Cross-reactivity prediction: Algorithms to predict potential off-target binding
Image analysis automation: Deep learning for quantitative analysis of immunohistochemistry
Structure prediction: Modeling antibody-antigen interactions through AlphaFold-type approaches
Data integration platforms:
Integration of antibody-based data with transcriptomics and proteomics
Network analysis to place At5g05820 in functional context
Automated literature mining to synthesize published findings
Impact on experimental design and analysis:
| Research Phase | Computational Approach | Expected Impact |
|---|---|---|
| Antibody design | Epitope prediction algorithms | More specific antibodies with reduced cross-reactivity |
| Validation | Automated image analysis | Higher throughput, more objective assessment |
| Data analysis | Pattern recognition in complex datasets | Detection of subtle phenotypes and correlations |
| Literature review | Natural language processing | Comprehensive synthesis of published results |
These computational approaches will enable more efficient antibody development, more objective data analysis, and more comprehensive integration of At5g05820 research with broader plant biology knowledge.